For more information on

In the framework of the BioMedaqu Project, the University of Liege and partners are offering a training course covering:

• Fish skeletal development and anatomy • Advanced visualisation technique for fish skeletal research • Image analysis, machine learning and automation • Skeletal pathologies in humans • Leadership, research impact, grant funding, entrepreneurship, product development & market, and economic modelling.

Registration open until 21st February 2020.
For more information, email: info.biomedaqu@uliege.be, specifying in the subject line 'BIOMEDAQU Summer School'.

Event Website | Project in Cordis | Project Website

Join a major event on rare diseases in 2020: The RE(ACT) Congress and IRDiRC Conference, 11-14 March 2020, Meliá Berlin Hotel, Berlin.

Young and professional scientists, patients & patient representatives, and other rare diseases stakeholders are welcome to discuss latest cutting-edge research, innovation, and policy with the rare disease leaders.

The scientific program -inspired by IRDiRC principles, achievements, and activities foreseen in 2020- encompasses topics like diagnosis & artificial intelligence, molecular etiology, innovative clinical trials, patient engagement and drugs for all.

Blackswan Foundation and IRDiRC in collaboration with EJP RD organize this exceptional joint edition.

In this one-day event, HBP experts and leadership will present EBRAINS infrastructure, and demonstrate the capacities of the underlying HBP platforms.
They will present a range of opportunities for engagement of researchers in the project’s activities. These presentations will be coupled with talks by Dutch researchers, that may be interested in using HBP facilities in the near future. The event will be open for the wider research community.
14 February 2020 | Amsterdam, Netherlands

• Preliminary Agenda • Registration

Disposable nappies, or diapers, are a hygienic time-saver - but one with an environmental impact. An EU and industry-funded project has developed collection and recycling systems that turn used nappies and similar products into profitable new materials for more sustainable use.

The potential for new advances drawing on medical physics and biomedical engineering is vast. Cross-disciplinary expertise is needed to unlock it for the benefit of society and industry, say the partners in an EU-funded network that is helping 15 young researchers to hone the required skills.

An innovative Swedish SME will soon launch a life-saving test for one of the most lethal and hard-to-detect forms of cancer. Clinically validated in an EU-funded project, the test could revolutionise the diagnosis of pancreatic cancer, providing early detection with unprecedented accuracy, boosting patient survival rates and enabling widespread screening of high-risk groups.

An EU-funded project is taking an innovative multi-disciplinary approach to improving our understanding of food choices. Knowledge gained will help policy-makers to 'nudge' people into eating more healthily, so reducing the incidence of food-intake disorders.

Are you likelier than others to develop type 2 diabetes? Lifestyle changes could dramatically reduce the risk, but you may need advice and support to make them. EU-funded researchers are trialling an affordable way for healthcare systems to make effective assistance available across entire populations - with a little help from patients' families.

An EU-funded project is integrating research resources and providing services to support access to specific mouse models for scientific investigation of the genetic foundations of human health and disease. The aim is to boost the translation of this knowledge into better treatments for patients.

After 117 interviews at dairy plants in 14 European countries, 53 interviews with dairy educational institutions and 65 ex-students, AEDIL is now ready to present Results & Recommendations based on the analysis of this vast amount of data.

We are very pleased to invite you to Leeuwarden, The Netherlands on the 26th of November and the 27th of November to:

• Hear and see the results from this Erasmus+ project ‘Mapping skills needs and supply in the dairy sector’. • Hear the recommendations we wish to give back to the dairy sector based on the analysis of data and inputs from experts. • Give your inputs on how best to roll out the recommendations in your country and at a pan-European level.

The workshop is organised by CARAT in collaboration with BIO.NRW.

Advances in CAR-T cell develoment made with in CARAT will be presented. Further, various aspects such as production, application and reimbursement options for this novel therapeutic approach will be examined. In addition to scientific lectures, a panel discussion on opportunities and threats of the broad application of CAR-T cell therapies from different viewpoints will be held.

Please register until November 26, 2019 by email:
Dr Martina Wessling: m.wessling@bio.nrw.de
Tel: +49 211 385 469-9205

Venue: Representation of the State of North Rhine-Westphalia to the European Union
Rue Montoyer 47
1000 Brussels

EU-funded researchers have developed a fresh 'benign-by-design' approach to balancing the commercial and societal benefits of nanomaterial innovations and their environmental impacts, which are notoriously difficult to pinpoint.

EU-funded researchers studied the way attention affects how we perceive pain, in the hope of improving the performance of psychological methods for treating chronic pain for the millions of people around the world who suffer from it.

EU-funded researchers have demonstrated a new type of biomedical sensor featuring embedded intelligence. The sensor measures ion concentrations but the computing principles have far-reaching implications for all kinds of biomedical and environmental sensing.

EU-funded researchers have developed a hands-free, voice-controlled system for smart homes to facilitate and improve the day-to-day lives of seniors and the disabled, enabling them to operate appliances and go online without ever touching a device.

Miniscule messenger bubbles floating in all your bodily fluids could hold important insights into many complex diseases from Alzheimer's to heart disease - if they can be isolated, analysed and their messages decoded. An EU-funded researcher has made significant strides toward achieving that goal.

A wide-reaching EU-funded project is testing new anti-blood clotting treatment in patients who have suffered a brain haemorrhage. Researchers hope to reduce the risk of the patient suffering from another stroke, which would impair their quality of life and life expectancy.

The ​Belgian ​capital ​has ​been ​chosen ​to ​host ​the ​event ​as ​the ​new ​Parliament ​will ​be ​in ​place ​after ​the ​summer ​elections, ​while ​a ​new ​European ​Commission ​will ​be ​in ​the ​process ​of ​being ​formed, ​ready ​to ​formally ​move ​into ​the ​Berlaymont ​not ​long ​afterwards.
The ​event ​will ​be ​held ​under ​the ​auspices ​of ​the ​Finnish ​Presidency ​of ​the ​EU, ​which ​will ​run ​from ​July ​to ​December. The ​Congress ​is ​in ​a ​focused ​format ​to ​allow ​concrete ​issues ​to ​be ​tackled ​and ​to ​have ​a ​dialogue ​with ​our ​policy ​makers. Essentially, ​this ​3rd ​annual ​Congress ​will ​provide ​the ​ideal ​space ​to ​allow ​for ​a ​meeting ​of ​minds ​and ​expertise ​and ​represent ​a ​vital ​opportunity ​for ​top-level ​discussion ​and the ​formulation ​of ​real ​action ​plans, ​for ​example ​in ​the ​area ​of ​translational ​research.
Congress ​will ​showcase ​different ​objectives ​which ​both ​the ​public ​and ​private ​sector ​can ​support, ​with ​a ​view ​to ​allowing ​the ​EU ​to ​present ​a ​common ​objective. Innovation ​and ​the ​incentives ​for ​it ​are ​key ​to ​health ​and ​wealth ​in ​the ​current ​EU-28 ​(and ​will ​be ​even ​more ​important ​after ​the ​UK ​leaves). It ​also ​encourages ​investment ​from ​outside ​of ​the ​EU, ​which ​is ​good ​for ​business ​and ​jobs. It ​is ​clear ​that ​innovation ​needs ​to ​soar ​to ​new ​heights, ​and ​be ​implemented ​and ​integrated, ​for ​the ​bene ​t ​of ​EU ​citizens.

A wide-reaching EU-funded clinical trial is testing thrombectomies for severe stroke patients. Researchers hope to show that the treatment - which is only currently available for those who have suffered less severe strokes - can also improve the lives of severe stroke patients.